Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HPRT1 | P00492 | 12/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | VCP | P55072 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | PNP | P00491 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23258833 | 1.00 | HSD17B10 (0.39) | HSD17B10ALDH1A1KDM4ETDP1HPRT1 | |
| SCHEMBL22847431 | 0.86 | ALDH1A1 (0.35) | HSD17B10ALDH1A1KDM4ETDP1HPRT1 | |
| SCHEMBL22781141 | 0.81 | HPRT1 (0.55) | HPRT1PNP | |
| SCHEMBL22846919 | 0.78 | LMNA (0.34) | ALDH1A1MEN1LMNACYP3A4NFKB1 | |
| SCHEMBL28275704 | 0.75 | ALDH1A1 (0.48) | HSD17B10ALDH1A1KDM4ETDP1HPRT1 | |
| SCHEMBL7147173 | 0.74 | AHCY (0.45) | HSD17B10ALDH1A1KDM4ETDP1HPRT1 | |
| SCHEMBL25604296 | 0.71 | MEN1 (0.30) | ALDH1A1MEN1LMNACYP3A4NFKB1 | |
| SCHEMBL11270399 | 0.71 | HSD17B10 (0.49) | HSD17B10ALDH1A1KDM4ETDP1HPRT1 | |
| SCHEMBL18758938 | 0.71 | BLM (0.68) | HSD17B10ALDH1A1HPRT1MEN1LMNA | |
| SCHEMBL454682 | 0.69 | ALDH1A1 (0.71) | HSD17B10ALDH1A1KDM4ETDP1HPRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230173079-A1 | Conjugate Molecules | DIVERSE BIOTECH, INC. (US) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173079-A1 | Conjugate Molecules | CNR2, CNR1, MAG | HSD17B10 3423/4885ALDH1A1 2054/4885KDM4E 1418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.